1 was effective in modulating cytokine expression in hMSCs with a decrease of TNF-α, IL-6, IL-8, the vascular endothelial growth factor (VEGF), and the basic fibroblast growth factor (FGF-2), and in reducing the proliferation, migration, and clonogenicity of human bladder (HTB-9) and 4T1 cancer cells [114]. This evidence concerns the gene VEGFA and cancer.